Nov. 28, 2022
Roche's Allosteric EGFR(L858R) Inhibitor and Degrader Progenitor
compound 57
oral EGFRL858R inhibitor efficacy in EGFR mutant mouse models SBDD opt. from previously disclosed EGFRai J. Med. Chem. F. Hoffmann-La Roche, Basel, CH
oral EGFRL858R inhibitor efficacy in EGFR mutant mouse models SBDD opt. from previously disclosed EGFRai J. Med. Chem. F. Hoffmann-La Roche, Basel, CH